CC
VRTX icon

Corsicana & Co’s Vertex Pharmaceuticals VRTX Stock Holding History

Corsicana & Co’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.98K Hold
6
– – ﹤0.01% 275
2026
Q1 		$2.91K Hold
6
– – ﹤0.01% 239
2025
Q4 		$2.72K Hold
6
– – ﹤0.01% 238
2025
Q3 		$2.35K Buy
+6
New +$2.51K ﹤0.01% 241

Other funds holding VRTX

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Corsicana & Co's VRTX Position: Q2 2026 in Review

Corsicana & Co held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 6 shares worth $2.98K. The position accounts for ﹤0.01% of the portfolio, ranked #275.

Corsicana & Co first reported a position in VRTX in Q3 2025 and has held it in 4 quarters since. 823 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Corsicana & Co held 6 shares of Vertex Pharmaceuticals worth $2.98K as of Q2 2026.
  • Corsicana & Co left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up ﹤0.01% of Corsicana & Co's portfolio in Q2 2026, its #275 holding.
  • Corsicana & Co first reported a position in Vertex Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 823 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Corsicana & Co's 13F filing for Q2 2026, filed 24 Jul 2026.